Effectiveness of pharmacological interventions for managing obesity in children and adolescents: A systematic review and meta-analysis framed using minimal important difference estimates based on GRADE guidance to inform a clinical practice guideline.
針對兒童和青少年肥胖管理的藥物介入效果:一項系統性回顧和元分析,基於 GRADE 指導的最小重要差異估計來制定臨床實踐指導。
Pediatr Obes 2024-09-06
Long-Term Metabolic Dysfunction Programming in Female Mice by Serial Moderate Restriction of High Fat High Sucrose Diet.
女性小鼠在高脂高糖飲食下經歷序列性中度限制所導致的長期代謝功能障礙編程。
Endocrinology 2024-09-05
Laxative Properties of Microencapsulated Oleic Acid Delivered to the Distal Small Intestine in Patients with Constipation after Bariatric Surgery or Treatment with Glucagon-Like- Peptide 1 Analogues.
微膠囊包覆的油酸在接受減重手術或使用Glucagon-Like Peptide 1 類似物的便秘患者中,對於遠端小腸的瀉藥特性。
Obes Surg 2024-09-05
Cardiovascular and diabetes outcomes among patients with obesity and type 2 diabetes after metabolic bariatric surgery or glucagon-like peptide 1 receptor agonist treatment.
肥胖及第二型糖尿病患者在接受代謝性減重手術或胰高血糖素樣肽-1受體激動劑治療後的心血管及糖尿病結果。
Br J Surg 2024-09-05
這項研究比較了代謝性減重手術(如Roux-en-Y胃旁路手術和袖狀胃切除術)與胰高血糖素樣肽-1受體激動劑在2型糖尿病和肥胖患者中的效果,隨訪平均7年。結果顯示,手術組的重大心血管事件發生率較低(14.5% vs 19.6%),血紅素A1c水平顯著下降,且微血管併發症風險減少。然而,手術組也面臨較高的酒精/物質濫用、自我傷害和骨折風險。因此,雖然手術有助於改善代謝狀況,但需注意潛在的不良後果。
相關文章PubMedDOI